DARE - Dare Bioscience GAAP EPS of -$0.09 May, 11 2023 11:45 AM Dare Bioscience Inc. 2023-05-11 11:45:10 ET Dare Bioscience press release ( NASDAQ: DARE ): Q1 GAAP EPS of -$0.09. Cash and cash equivalents: $19.8 million at March 31, 2023. For further details see: Dare Bioscience GAAP EPS of -$0.09